New Drugs FDA Approves Keytruda (pembrolizumab) for Patients With BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer 5 years ago
Pharma Industry News Improve brand and batch number recording, urge drug safety professionals 5 years ago